These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6807837)

  • 21. Independence of reciprocal attachment sites on denatured collagen and fibronectin from antigenic sites, and binding of gelatin-based plasma substitutes to plasma fibronectin.
    Adelmann-Grill BC
    Coll Relat Res; 1981 Jul; 1(4):367 -75. PubMed ID: 6179705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphokine-like products of cultured tumour cells.
    Inoue Y; Geczy CL; Nelson DS; Nelson M
    Immunology; 1983 Apr; 48(4):713-22. PubMed ID: 6832804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding.
    Villiger B; Kelley DG; Engleman W; Kuhn C; McDonald JA
    J Cell Biol; 1981 Sep; 90(3):711-20. PubMed ID: 7287821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sinusoidal endothelial cells from guinea pig liver synthesize and secrete cellular fibronectin in vitro.
    Rieder H; Ramadori G; Dienes HP; Meyer zum Büschenfelde KH
    Hepatology; 1987; 7(5):856-64. PubMed ID: 3308666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin promotes epithelial migration of cultured rabbit cornea in situ.
    Nishida T; Nakagawa S; Awata T; Ohashi Y; Watanabe K; Manabe R
    J Cell Biol; 1983 Nov; 97(5 Pt 1):1653-7. PubMed ID: 6415071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An assay for macrophage activating factor based on the adherence of oil-elicited guinea pig macrophages: characterization of a lymphokine-induced release of hydrogen peroxide from elicited macrophages.
    Talmadge KW; Peck R
    Lymphokine Res; 1986; 5(1):35-47. PubMed ID: 3511329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Fc and C3b receptor expression on guinea-pig macrophages by lymphokines.
    Limb GA; Brown KA; Wolstencroft RA; Ellis BA; Dumonde DC
    Clin Exp Immunol; 1988 Nov; 74(2):171-6. PubMed ID: 2975973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell fibronectin: an unexpected inflammatory lymphokine.
    Godfrey HP
    Lymphokine Res; 1990; 9(3):435-47. PubMed ID: 2144604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The purification and biological activity of a macrophage-derived factor with interleukin 1-like activities from guinea pigs.
    Onoue K; Sasaki T; Yamamoto Y; Lin BH; Matsuda H
    Biochim Biophys Acta; 1986 May; 881(3):437-45. PubMed ID: 3083870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin.
    Radek JT; Jeong JM; Murthy SN; Ingham KC; Lorand L
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3152-6. PubMed ID: 8097314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation and characterization of fibronectin domains by two-dimensional electrophoresis.
    Edwards JJ; Reeder DJ; Atha DH
    Appl Theor Electrophor; 1990; 1(4):207-12. PubMed ID: 2098103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural comparisons of fibronectins isolated from early and late passage cells.
    Sorrentino JA; Millis AJ
    Mech Ageing Dev; 1984 Nov; 28(1):83-97. PubMed ID: 6513615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
    Sorg C
    Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on properties of guinea pig peritoneal macrophage Fc receptor.
    Janusz M; Ugorski M; Mikulska J; Starościk K; Wieczorek Z; Lisowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):275-85. PubMed ID: 7447640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of a lymphokine-like plasminogen activator by stimulated B lymphocytes.
    Toullet F; Maillard JL; Favreau C
    J Immunol; 1983 Jan; 130(1):254-60. PubMed ID: 6600183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.